Ireland· IE-PA-EU/1/22/1699/004
Qdenga powder and solvent for solution for injection
A dengue-virus-impfstoffe product, registered in Ireland by Takeda Pharmaceuticals International AG Ireland Branch. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Dengue-virus-impfstoffe is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BX04 (dengue-virus-impfstoffe), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Dengue-virus-impfstoffe · ATC J07BX04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Manufacturer
- Takeda Pharmaceuticals International AG Ireland Branch
- Country
- Ireland (IE)
- ATC code
- J07BX04
- ATC class
- Dengue-Virus-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/22/1699/004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX04
Dengue-virus-impfstoffe, as other registers publish it.
- FinlandDengvaxiaSanofi Winthrop Industrie
- FinlandDengvaxiaSanofi Winthrop Industrie
- PolandDengvaxiaSanofi Pasteur
- BelgiumDengvaxiaSanofi Winthrop Industrie
- DenmarkDengvaxiaSanofi Winthrop Industrie
- BelgiumDengvaxiaSanofi Winthrop Industrie
- PolandQdengaTakeda Pharmaceuticals International AG Ireland Branch
- FinlandQdengaTakeda Pharmaceuticals International AG Ireland Branch
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad56213c-356d-4951-8430-3c321b9a2db5 GET /v1/drugs/ad56213c-356d-4951-8430-3c321b9a2db5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"J07B",
"J07BX04"
],
"strength": null,
"pa_number": "EU/1/22/1699/004",
"substances": [
"Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated",
"Dengue virus, serotype 2, live, attenuated",
"Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated",
"Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "05/12/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about dengue-virus-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.